Contrast-enhanced CT-Derived extracellular volume fraction predicts survival in postoperative pancreatic cancer patients
Shuai Ming(University of Science and Technology of China), Wei Wei(Zhujiang Hospital), Mengru Li(University of Science and Technology of China), Wuyang Zhang(University of Science and Technology of China), Min Wang(Alvin J. Siteman Cancer Center), Bin Wang(Longgang Central Hospital), Jingyu Li(Ministry of Education of the People's Republic of China), Yadi Zhang(Peking University), Aiyun Sun(General Electric (Spain)), Dan Shi(University of Science and Technology of China), Chenglin Zhu(Southwest Minzu University)
Cited by 2
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216